Valued at $230.0M at its later-stage round, Apr 2026. Nothing has traded since.
- ·The complete investor list: 12 names
- ·Watch ReAlta Life Sciences: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
ReAlta Life Sciences funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2024 | Early Stage VC | $25.0M | ▮ | ▮ |
| Nov 2023 | Early Stage VC | $29.9M | ▮ | ▮ |
| Feb 2023 | Early Stage VC | $12.0M | ▮ | ▮ |
| Dec 2020 | Early Stage VC | $22.5M | ▮ | ▮ |
| Sep 2018 | Seed Round | $4.8M | ▮ | ▮ |
Membership and data by Private Market View
ReAlta Life Sciences valuation
ReAlta Life Sciences was valued at $230 million at its later-stage round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has ReAlta Life Sciences raised?
ReAlta Life Sciences has raised $155 million across 5 recorded rounds since 2018. The largest was a $4.8 million seed round in Sep 2018; the most recent was a $25 million early-stage round in Dec 2024.
ReAlta Life Sciences has filed 7 Form Ds with the SEC since 2018, most recently in May 2025 ($12 million sold to 85 investors).
How ReAlta Life Sciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ReAlta Life Sciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about ReAlta Life Sciences
- What is ReAlta Life Sciences worth?
- ReAlta Life Sciences is valued at $230.0M as of Oct 2026. Valued at $230.0M at its later-stage round, Apr 2026. Nothing has traded since.
- How much has ReAlta Life Sciences raised?
- ReAlta Life Sciences has raised $155.4M in total funding across 5 recorded rounds.
- When did ReAlta Life Sciences last raise?
- ReAlta Life Sciences last raised in Dec 2024 (Early Stage VC), raising $25.0M.